Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP411991.RAG3rtLgLCz9UwsAsEqtdNGMlrIjQOyF8xnw1OMbLK-Ws130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP411991.RAG3rtLgLCz9UwsAsEqtdNGMlrIjQOyF8xnw1OMbLK-Ws130_assertion type Assertion NP411991.RAG3rtLgLCz9UwsAsEqtdNGMlrIjQOyF8xnw1OMbLK-Ws130_head.
- NP411991.RAG3rtLgLCz9UwsAsEqtdNGMlrIjQOyF8xnw1OMbLK-Ws130_assertion description "[In contrast, SOCE agonists should attenuate mTOR inhibitors-mediated AKT reactivation and consequently potentiate their efficacy in the treatment of the patients with TSC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411991.RAG3rtLgLCz9UwsAsEqtdNGMlrIjQOyF8xnw1OMbLK-Ws130_provenance.
- NP411991.RAG3rtLgLCz9UwsAsEqtdNGMlrIjQOyF8xnw1OMbLK-Ws130_assertion evidence source_evidence_literature NP411991.RAG3rtLgLCz9UwsAsEqtdNGMlrIjQOyF8xnw1OMbLK-Ws130_provenance.
- NP411991.RAG3rtLgLCz9UwsAsEqtdNGMlrIjQOyF8xnw1OMbLK-Ws130_assertion SIO_000772 23108404 NP411991.RAG3rtLgLCz9UwsAsEqtdNGMlrIjQOyF8xnw1OMbLK-Ws130_provenance.
- NP411991.RAG3rtLgLCz9UwsAsEqtdNGMlrIjQOyF8xnw1OMbLK-Ws130_assertion wasDerivedFrom befree-20150227 NP411991.RAG3rtLgLCz9UwsAsEqtdNGMlrIjQOyF8xnw1OMbLK-Ws130_provenance.
- NP411991.RAG3rtLgLCz9UwsAsEqtdNGMlrIjQOyF8xnw1OMbLK-Ws130_assertion wasGeneratedBy ECO_0000203 NP411991.RAG3rtLgLCz9UwsAsEqtdNGMlrIjQOyF8xnw1OMbLK-Ws130_provenance.